Considering its low sensitivity and NPV values, in addition to its low frequency in indeterminate nodules, the BRAF mutational testing could only be useful if implemented in combination with other diagnostic criteria, such as ultrasonography, in order to contribute to diagnosis and surgical decision-making during the initial management of thyroid nodules in Mexican hospitals. This evidence concerns the gene BRAF and thyroid nodule.